CVRx to Report Fourth Quarter 2023 Financial and Operating Results and Host Conference Call on January 25th, 2024
11 Enero 2024 - 3:30PM
CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical
device company focused on developing, manufacturing and
commercializing Barostim™, an innovative extravascular implantable
neuromodulation device for patients with cardiovascular diseases,
today announced that it plans to release fourth quarter 2023
financial and operating results after market close on Thursday,
January 25th, 2024. The Company will host a conference call to
review its results at 4:30pm Eastern Time the same day.
A live webcast of the investor conference call will be available
online at the investor relations page of the Company’s website at
ir.cvrx.com. To listen to the conference call on your telephone,
please dial 1-877-704-4453 for U.S. callers, or 1-201-389-0920 for
international callers, approximately ten minutes prior to the start
time.
About CVRx, Inc.
CVRx is a commercial-stage medical device company focused on the
developing, manufacturing and commercializing innovative
neuromodulation solutions for patients with cardiovascular
diseases. Barostim™ is the first medical technology approved by FDA
that uses neuromodulation to improve the symptoms of patients with
heart failure. Barostim is an implantable device that delivers
electrical pulses to baroreceptors located in the wall of the
carotid artery. The therapy is designed to restore balance to the
autonomic nervous system and thereby reduce the symptoms of heart
failure. Barostim received the FDA Breakthrough Device designation
and is FDA-approved for use in heart failure patients in the U.S.
It has also received the CE Mark for heart failure and resistant
hypertension in the European Economic Area. To learn more about
Barostim, visit www.cvrx.com.
Investor Contact:Mark Klausner or Mike VallieICR
Westwicke443-213-0501ir@cvrx.com
Media Contact:Laura O’NeillFinn
Partners212-867-1762laura.oneill@finnpartners.com
CVRx (NASDAQ:CVRX)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
CVRx (NASDAQ:CVRX)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024